False
By Katherine Tran
August 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
July 27, 2026
How advances in microarray technology are helping bring genomic data closer to real-time clinical decision-making
4 min read
By Christina Casén
July 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
July 2, 2026
This month’s analytical science business news: Merck’s Bio-Techne acquisition, plus major ASMS product launches
3 min read
June 15, 2026
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
6 min read
June 10, 2026
Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics
13 min read
June 9, 2026
Ahead of ISC2026 in Prague, Koen Sandra explores how analytical scientists are rising to the challenge posed by increasingly intimidating biotherapeutics
11 min read
June 8, 2026
As vaccine technologies continue to expand, David Hage explores how analytical methods must evolve to meet growing demands for safety, quality, and activity testing
9 min read
By James Strachan
May 25, 2026
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
5 min read
By James Strachan
May 8, 2026
Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients
11 min read
False